A detailed history of Keel Point, LLC transactions in Haleon PLC stock. As of the latest transaction made, Keel Point, LLC holds 13,665 shares of HLN stock, worth $132,550. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,665
Previous 13,574 0.67%
Holding current value
$132,550
Previous $112,000 28.57%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.32 - $10.7 $757 - $973
91 Added 0.67%
13,665 $144,000
Q2 2024

Aug 14, 2024

BUY
$8.01 - $8.64 $13,112 - $14,143
1,637 Added 13.71%
13,574 $112,000
Q1 2024

Apr 16, 2024

BUY
$8.02 - $8.67 $433 - $468
54 Added 0.45%
11,937 $101,000
Q4 2023

Jan 30, 2024

BUY
$7.78 - $8.62 $925 - $1,025
119 Added 1.01%
11,883 $97,000
Q3 2023

Oct 26, 2023

BUY
$7.85 - $8.94 $92,347 - $105,170
11,764 New
11,764 $97,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Keel Point, LLC Portfolio

Follow Keel Point, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.